These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? Hay JE Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489 [TBL] [Abstract][Full Text] [Related]
3. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Wiesner RH; Porayko MK; Dickson ER; Gores GJ; LaRusso NF; Hay JE; Wahlstrom HE; Krom RA Hepatology; 1992 Nov; 16(5):1290-9. PubMed ID: 1427667 [TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for cholestatic liver disease: screening and assessment of risk factors. Crippin JS Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S2-8. PubMed ID: 9742488 [TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models. Wiesner RH Mayo Clin Proc; 1998 Jun; 73(6):575-88. PubMed ID: 9621867 [TBL] [Abstract][Full Text] [Related]
6. A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. McEntee G; Wiesner RH; Rosen C; Cooper J; Wahlstrom E Transplant Proc; 1991 Feb; 23(1 Pt 2):1563-4. PubMed ID: 1989291 [No Abstract] [Full Text] [Related]
7. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Maheshwari A; Yoo HY; Thuluvath PJ Am J Gastroenterol; 2004 Mar; 99(3):538-42. PubMed ID: 15056099 [TBL] [Abstract][Full Text] [Related]
8. The optimal timing of liver transplantation in patients with chronic cholestatic liver disease. Rave S; Schalm SW; Transpl Int; 2005 Aug; 18(8):937-40. PubMed ID: 16008743 [TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in PBC and PSC: indications and disease recurrence. Carbone M; Neuberger J Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):446-54. PubMed ID: 21459072 [TBL] [Abstract][Full Text] [Related]
10. Current management of primary biliary cirrhosis and primary sclerosing cholangitis. Levy C; Lindor KD J Hepatol; 2003; 38 Suppl 1():S24-37. PubMed ID: 12591184 [No Abstract] [Full Text] [Related]
12. Liver transplantation in autoimmune liver disease--selection of patients. Tillmann HL; Jäckel E; Manns MP Hepatogastroenterology; 1999; 46(30):3053-9. PubMed ID: 10626159 [TBL] [Abstract][Full Text] [Related]
13. Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups. Longworth L; Young T; Buxton MJ; Ratcliffe J; Neuberger J; Burroughs A; Bryan S; Liver Transpl; 2003 Dec; 9(12):1295-307. PubMed ID: 14625830 [TBL] [Abstract][Full Text] [Related]
14. [Indications and results of liver transplantation in cholestatic diseases]. de la Mata M; Montero JL; Fraga E; Delgado M; Costán G; Padillo J; Díaz C; Rufián S; López-Cillero P; Solórzano G; Pera C; Miño G Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():39-42. PubMed ID: 11968341 [No Abstract] [Full Text] [Related]
15. [Recurrence of chronic cholestatic liver diseases following liver transplantation]. Cirera I Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():77-80. PubMed ID: 11968350 [No Abstract] [Full Text] [Related]
16. Liver transplantation in autoimmune liver diseases. Ilyas JA; O'Mahony CA; Vierling JM Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):765-82. PubMed ID: 22117641 [TBL] [Abstract][Full Text] [Related]